| PERIOD ENDING | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 212,540 | 172,320 | 202,025 | 271,669 | | Cost of Revenue | 138,539 | 142,487 | 163,613 | 194,900 | | | Gross Profit | 74,001 | 29,833 | 38,412 | 76,769 | | | Operating Expenses | | Research Development | 35,633 | 35,744 | 38,617 | 45,063 | | Selling General and Administrative | 26,317 | (749,952) | 753,821 | 50,751 | | Non Recurring |
-
| 800,563 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,051 | (56,522) | (754,026) | (19,045) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,217 | 11,733 | 6,316 | 2,389 | | Earnings Before Interest And Taxes | 14,268 | (44,789) | (747,710) | (16,656) | | Interest Expense | 6,414 | 2,400 | 2,501 | 2,677 | | Income Before Tax | 7,854 | (47,189) | (750,211) | (19,333) | | Income Tax Expense | 3,070 | 2,190 | 63,132 | (7,554) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,784 | (49,379) | (813,343) | (11,779) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,784 | (49,379) | (813,343) | (11,779) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,784 | ($49,379) | ($813,343) | ($11,779) |
|
2.03% Nasdaq 0.00%
Income Statement
